Minoxidil still has substantially more human RCT evidence for regrowth than any copper peptide
Historically, it has even been used in clinical settings to treat certain types of beta-blocker overdose due to these properties
academic.oup.com/jes/article/9/ GLP-1 in addiction medicine: GLP-1 acts on pancreas, gut, kidney, heart and thyroid receptors to activate reward/stress hubs (VTA, NAc, ARC, PFC, hypothalamus)
The semaglutide revolution First developed in 2012 by researchers at Danish pharmaceutic company Novo Nordisk, semaglutide is one of a new class of powerful medications called glucagon-like peptide-1 receptor agonists or GLP-1s
10.1002/jnr.20573 J
GIP is highly expressed in the brain, which may mediate satiety, promote energy expenditure, and enhance peripheral glucose metabolism